Literature DB >> 33888775

Rapid uropathogen identification using surface enhanced Raman spectroscopy active filters.

Alex J Thompson1,2,3, Daniel R Leff4,5, Ara Darzi4,5, Simon D Dryden6, Salzitsa Anastasova5, Giovanni Satta7.   

Abstract

Urinary tract infection is one of the most common bacterial infections leading to increased morbidity, mortality and societal costs. Current diagnostics exacerbate this problem due to an inability to provide timely pathogen identification. Surface enhanced Raman spectroscopy (SERS) has the potential to overcome these issues by providing immediate bacterial classification. To date, achieving accurate classification has required technically complicated processes to capture pathogens, which has precluded the integration of SERS into rapid diagnostics. This work demonstrates that gold-coated membrane filters capture and aggregate bacteria, separating them from urine, while also providing Raman signal enhancement. An optimal gold coating thickness of 50 nm was demonstrated, and the diagnostic performance of the SERS-active filters was assessed using phantom urine infection samples at clinically relevant concentrations (105 CFU/ml). Infected and uninfected (control) samples were identified with an accuracy of 91.1%. Amongst infected samples only, classification of three bacteria (Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae) was achieved at a rate of 91.6%.

Entities:  

Year:  2021        PMID: 33888775     DOI: 10.1038/s41598-021-88026-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  31 in total

Review 1.  The diagnosis of urinary tract infection: a systematic review.

Authors:  Guido Schmiemann; Eberhardt Kniehl; Klaus Gebhardt; Martha M Matejczyk; Eva Hummers-Pradier
Journal:  Dtsch Arztebl Int       Date:  2010-05-28       Impact factor: 5.594

Review 2.  Characterisation and identification of bacteria using SERS.

Authors:  Roger M Jarvis; Royston Goodacre
Journal:  Chem Soc Rev       Date:  2008-03-26       Impact factor: 54.564

3.  Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer.

Authors:  Maarten A C Broeren; Semiha Bahçeci; Huib L Vader; Niek L A Arents
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

Review 4.  Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.

Authors:  Carl Llor; Lars Bjerrum
Journal:  Ther Adv Drug Saf       Date:  2014-12

Review 5.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

6.  Narrow-spectrum, compared with broad-spectrum, antibiotics equally effective with less adverse events.

Authors:  Kevin Messacar
Journal:  J Pediatr       Date:  2018-05       Impact factor: 4.406

7.  Epidemiology of urological infections: a global burden.

Authors:  Recep Öztürk; Ahmet Murt
Journal:  World J Urol       Date:  2020-01-10       Impact factor: 4.226

8.  Narrow-Spectrum Antibacterial Agents.

Authors:  Roberta J Melander; Daniel V Zurawski; Christian Melander
Journal:  Medchemcomm       Date:  2017-11-06       Impact factor: 3.597

Review 9.  Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden.

Authors:  Betsy Foxman
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.982

Review 10.  Epidemiology of severe sepsis.

Authors:  Florian B Mayr; Sachin Yende; Derek C Angus
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

View more
  1 in total

1.  Rapid identification of the resistance of urinary tract pathogenic bacteria using deep learning-based spectroscopic analysis.

Authors:  Qiuyue Fu; Yanjiao Zhang; Peng Wang; Jiang Pi; Xun Qiu; Zhusheng Guo; Ya Huang; Yi Zhao; Shaoxin Li; Junfa Xu
Journal:  Anal Bioanal Chem       Date:  2021-10-21       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.